Europe Breast Cancer Screening Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Test Type (Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test), End User (Hospitals, Diagnostic Centers, Cancer Institutes, Research Laboratories), and Country
The Europe breast cancer screening market was valued at US$ 1,231.82 million in 2019 and is projected to reach US$ 1,586.46 million by 2027; it is expected to grow at CAGR of 4.3% from 2020 to 2027.
Breast cancer is formed in the lobules, duct, fatty tissue, or fibrous connective tissue in breasts. Thus, ductal, lobular, invasive ductal, and invasive lobular carcinomas are the common types of breast cancer. Breast cancer has no symptoms in early stages;however, a lump in the breast can be the first sign of the development of breast cancer.
Germany Breast Cancer Screening Market Revenue and Forecast to 2027 (US$ Million)
Get more information on this report :
Market Insghts
Growing Initiatives for Breast Cancer Management
Growing grants and initiatives is favoring the growth of the breast cancer screening market. Breast cancer screening plays a significant role in determining the suitable procedure and required pace of treatment.Early screening reduces mortality rates due tobreast cancers; therefore, market players, as well as government authorities, are implementing new diagnostics or screening facilities. . The European Commission Initiative on Breast Cancer (ECIBC)develops the European Breast Guidelines andevidence-based references to provide women and healthcare providers bright, objective, and individualistic guidance on breast cancer screening and diagnosis.Additionally, the government provides funds for developing technologies for cancer detection. For instance, in February 2017, German genetic testing firm CeGaT received US$531,615 (€500,000) from the German Federal Ministry of Education and Research to support the development of liquid biopsy technology for the analysis of circulating tumor DNA.
Test Type-Based Market Insights
Based on test type,the breast cancer screeningmarket is further segmented into imaging test, immunohistochemistry test, genetic test, and blood marker test. The imaging testsegment held the largest share of the market in 2019,and it is also anticipated to register the highest CAGR in the market during the forecast period.
Europe Breast Cancer Screening Market, by Test Type– 2019and 2027
Get more information on this report :
End User-Based Market Insights
Based on end user, the breast cancer screeningmarketis segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019, and it is estimated to register the highest CAGR during the forecast period.
Strategic Insights
Product launches and approvalsarecommonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the breast cancer screeningmarketadopt the expansion, collaboration, and product launch strategies to enlarge customer base acrossthe world.These strategies allow the players to maintain their brand name globally. For instance, in May 2018, Siemens Healthineers and ScreenPoint Medical collaboratedtodesign breast imaging software basedon artificial intelligence. This joint partnership also includes Siemens Healthineers owning a strategic minority interest in ScreenPoint Medical.
By Test Type
- Blood Marker Test
- Imaging Test
- Genetic Test
- Immunohistochemistry Test
By End User
- Diagnostic Centres
- Hospitals
- Research Laboratories
- Cancer Institutes
By Country
- Germany
- UK
- France
- Italy
- Spain
Company Profiles
- Koninklijke Philips N.V.
- Hologic, Inc.
- Becton, Dickinson and Company
- Myriad Genetics, Inc.
- Siemens Healthcare AG
- Exact Sciences Corporation
- OncoCyte Corporation
- POC Medical Systems
- DanaherCorporation
- General Electric Company
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Breast Cancer Screening Market – By Test Type
1.3.2 Global Breast Cancer Screening Market – By End User
1.3.3 Europe Breast Cancer Screening Market– By Region
2. Breast Cancer Screening Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Breast Cancer Screening – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe
4.3 Expert Opinion
5. Europe Breast Cancer Screening Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Growing Breast Cancer Cases
5.1.2 Growing Initiatives for Breast Cancer Management
5.2 Key Market Restraints
5.2.1 High Cost Associated With Breast Cancer Screening
5.3 Key Market Opportunities
5.3.1 Product Launches Along With The Technological Advancements In Breast Imaging Modalities
5.4 Future Trends
5.4.1 Growing Agreements And Collaborations For Diagnostic Solutions
5.5 Impact Analysis
6. Breast Cancer Screening Market – Regional Analysis
6.1 Europe Breast Cancer Screening Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players
7. Breast Cancer Screening Market Analysis – By Test Type
7.1 Overview
7.2 Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)
7.2.1 Europe Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
7.3 Blood Marker Test
7.3.1 Overview
7.4 Blood Marker Tests: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Imaging Test
7.5.1 Overview
7.5.2 Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
7.6 Genetic Test
7.6.1 Overview
7.6.2 Genetic Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Immunohistochemistry Test
7.7.1 Overview
7.7.2 Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8. Breast Cancer Screening Market – By End User
8.1 Overview
8.2 Breast Cancer Screening Market, by End User, 2019 and 2027 (%)
8.2.1 Europe Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostics Centers
8.4.1 Overview
8.4.2 Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Research Laboratories
8.5.1 Overview
8.6 Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Cancer Institutes
8.7.1 Overview
8.8 Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
9. Breast Cancer Screening Market– Regional Analysis
9.1 Europe: Breast Cancer Screening Market
9.1.1 Overview
9.1.2 Europe: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 Europe: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.4 Europe: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.5 Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
9.1.6 Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Germany: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.6.3 Germany: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.7 UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 UK: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.7.3 UK: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.8 France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 France: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.8.3 France: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.9 Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 Spain: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.9.3 Spain: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.10 Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Italy: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.10.3 Italy: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic On Europe Breast Cancer Screening Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Breast Cancer Screening Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Breast Cancer Screening Market, 2016-2020
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Breast Cancer Screening Market – Key Company Profiles
12.1 General Electric Company
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Siemens Healthineers AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Exact Sciences Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips N.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hologic, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BD
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Myriad Genetics, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Oncocyte Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Danaher
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 POC Medical Systems
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Europe Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 3. Europe Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)
Table 4. Europe Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Germany Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Germany Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. UK Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 8. UK Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. France Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 10. France Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Spain Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Spain Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Italy Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Italy Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 15. Recent Inorganic Growth Strategies In The Breast Cancer Screening Market
Table 16. Recent Organic Growth Strategies In The Breast Cancer Screening Market
Table 17. Glossary of Terms, Breast Cancer Screening Market
LIST OF FIGURES
Figure 1. Breast Cancer Screening Market Segmentation
Figure 2. Breast Cancer Screening Segmentation – By Region
Figure 3. Europe Breast Cancer Screening Market Overview
Figure 4. The Imaging Test Segment Held Largest Share Of Test Type Segment In Breast Cancer Screening Market
Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Breast Cancer Screening Market, Industry Landscape
Figure 7. Europe PEST Analysis
Figure 8. Breast Cancer Screening Market Impact Analysis Of Driver And Restraints
Figure 9. Europe Breast Cancer Screening Market – Revenue Forecast And Analysis – 2019- 2027
Figure 10. Market Positioning Of Key Players In Breast Cancer Screening Market
Figure 11. Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)
Figure 12. Blood Marker Tests: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. Genetic Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 15. Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Breast Cancer Screening Market, by End User, 2019 and 2027 (%)
Figure 17. Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Europe: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)
Figure 22. Europe Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
Figure 23. Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
Figure 24. Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Impact of COVID-19 Pandemic In European Country Markets
Figure 30. Growth Strategies in The Breast Cancer Screening Market, 2016-2020
The List of Companies - Europe Breast Cancer Screening Market
- Koninklijke Philips N.V.
- Hologic, Inc.
- Becton, Dickinson and Company
- Myriad Genetics, Inc.
- Siemens Healthcare AG
- Exact Sciences Corporation
- OncoCyte Corporation
- POC Medical Systems
- DanaherCorporation
- General Electric Company
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Breast Cancer Screening Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.